We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 28, 2021

Clinical Features of Cyclophosphamide-Associated Bladder Cancer

Urologic Oncology: Seminars and Original Investigations


Additional Info

Disclosure statements are available on the authors' profiles:

Urologic Oncology: Seminars and Original Investigations
Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review
Urol. Oncol 2021 Oct 01;39(10)678-685, WH Chou, B McGregor, A Schmidt, FLF Carvalho, MS Hirsch, SL Chang, A Kibel, M Mossanen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading